This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The new law also expressly does not apply to any: financial institution or data subject to Gramm- Leach-Bliley Act); covered entity or business associate governed by HIPAA; nonprofit organization; or. institution of higher education.
Pharmacies, rehabilitation care, social care, medical research and pharmaceuticals all rely on this data being available to individuals delivering their services. Most data breaches occur as a result of human error , so when the number of individuals handling data increases, so do the potential risks.
However, the dataprivacy and data protection rules of many countries prohibit companies from transferring to the United States (or making accessible in the United States) documents containing personal information of persons within their countries (“data subjects”). 22-23, available at [link].
Across all segments of the industry – from payer, provider, biotech and pharmaceutical – organizations are ramping up on their digital transformation initiatives with a renewed sense of urgency. Lack of data management and poor-quality data drives up costs and risks. The Collibra Data Intelligence Cloud advantage.
We organize all of the trending information in your field so you don't have to. Join 55,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content